Humacyte Inc - HUMA STOCK NEWS

IMPACT

SENTIMENT

11/24/2023 08:00 AM

HUMA : Nasdaq

Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference

IMPACT

SENTIMENT

11/17/2023 08:00 AM

HUMA : Nasdaq

Humacyte Announces Two Presentations at the VEITHsymposium® of Positive Clinical Results of the Human Acellular Vessel™ (HAV™) in the Treatment of Vascular Trauma

IMPACT

SENTIMENT

11/09/2023 04:01 PM

HUMA : Nasdaq

Humacyte Third Quarter 2023 Financial Results and Business Update

IMPACT

SENTIMENT

11/02/2023 04:05 PM

HUMA : Nasdaq

Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 9, 2023

IMPACT

SENTIMENT

09/21/2023 04:05 PM

HUMA : Nasdaq

Humacyte to Present at the Cantor Global Healthcare Conference

IMPACT

SENTIMENT

09/18/2023 04:05 PM

HUMA : Nasdaq

Humacyte to Host In-Person KOL Event at the New York EDITION on September 20, 2023

IMPACT

SENTIMENT

09/12/2023 07:00 AM

HUMA : Nasdaq

Humacyte Announces Positive Top Line Results from Phase 2/3 Trial of Human Acellular Vessel™ (HAV™) in Treatment of Patients with Vascular Trauma

IMPACT

SENTIMENT

09/11/2023 05:00 PM

HUMA : Nasdaq

Humacyte to Announce Top Line Data from Phase 2/3 V005 Trial in Vascular Trauma Evaluating its Human Acellular Vessel™ (HAV™) Tuesday, September 12, 2023 at 8:00 AM ET

IMPACT

SENTIMENT

09/11/2023 08:00 AM

HUMA : Nasdaq

Results From Mayo Clinic Clinical Study of Humacyte’s Human Acellular Vessel™ (HAV™) in Treatment of Patients with Chronic Limb Ischemia Presented at Midwestern Vascular Conference

IMPACT

SENTIMENT

08/15/2023 08:00 AM

HUMA : Nasdaq

Humacyte Presents Clinical Performance of Human Acellular Vessel™ (HAV™) From Ukrainian Humanitarian Program

Humacyte Inc

Nasdaq:HUMA

HUMA Rankings

#4102 Ranked by Market Cap

N/A Ranked by Dividends

HUMA Stock Data

Industry Biological Product (except Diagnostic) Manufacturing

Sector Manufacturing

Website Link

Country United States

City Durham

About HUMA

biotechnology company